Combined 2D and 3D-QSAR, molecular modelling and docking studies of pyrazolodiazepinones as novel phosphodiesterase 2 inhibitors

References

• C.J. Woolf and Q. Ma, Nociceptors-noxious stimulus detectors, Neuron 55 (2007), pp. 353–364.
   PubMed Web of Science ®Google Scholar
• R.J. Chambers, K. Abrams, N.Y. Garceau, A.V. Kamath, C.M. Manley, S.C. Lilley, D.A. Otte, D.O. Scott, A.L. Sheils, D.A. Tess, A.S. Vellekoop, Y. Zhang, and K.T. Lam, A new chemical tool for exploring the physiological function of the PDE2 isozyme, Bioorg. Med. Chem. Lett. 16 (2006), pp. 307–310.
   PubMed Web of Science ®Google Scholar
• S.E. Martinez, A.Y. Wu, N.A. Glavas, X.B. Tang, S. Turley, W.G. Hol, and J.A. Beavo, The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding, Proc. Natl. Acad. Sci. U. S. A. 99 (2002), pp. 13260–13265.
   PubMed Web of Science ®Google Scholar
• R. Gupta, G. Kumar, and R.S. Kumar, An update on cyclicnucleotide phosphodi-esterase (PDE) inhibitors: Phosphodiesterases and drug selectivity, Meth. Find. Exp. Clin. Pharmacol. 27 (2005), pp. 101–118.
   PubMed Web of Science ®Google Scholar
• J. De Vente, M. Markerink-van Ittersum, and J.S.H. Vles, ANP-mediated cGMP signaling and phosphodiesterase inhibition in the rat cervical spinal cord, J. Chem. Neuroanat. 31 (2006), pp. 263–274.
   PubMed Web of Science ®Google Scholar
• I. Tegeder, A. Schmidtko, E. Niederberger, P. Ruth, and G. Geisslinger, Dual effects of spinally delivered 8-bromo-cyclic guanosine mono-phosphate (8-bromo-cGMP) in formalin-induced nociception in rats, Neurosci. Lett. 332 (2002), pp. 146–150.
   PubMed Web of Science ®Google Scholar
• T. Podzuweit, P. Nennstiel, and A. Müller, Isozyme selective inhibition of cGMP-stimulated cyclic nucleotide phosphodiesterases by erythro-9-(2-hydroxy-3-nonyl) adenine, Cell. Signalling 7 (1995), pp. 733–738.
   PubMed Web of Science ®Google Scholar
• C. Burnouf, A. Berecibar, and M. Navet, Novel substituted pyrazolo[4,3‒e] diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them, PCT Int. Appl. 34,211, WO2001049689 (2001).
   Google Scholar
• M.S. Plummer, J. Cornicelli, H. Roark, D.J. Skalitzky, C.J. Stankovic, S. Bove, J. Pandit, A. Goodman, J. Hicks, A. Shahripour, D. Beidler, X.K. Lu, B. Sanchez, C. Whitehead, R. Sarver, T. Braden, R. Gowan, X.Q. Shen, K. Welch, A. Ogden, N. Sadagopan, H. Baum, H. Miller, C. Banotai, C. Spessard, and S. Lightle, Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part I: Transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitors, Bioorg. Med. Chem. Lett. 23 (2013), pp. 3438–3442.
   PubMed Web of Science ®Google Scholar
• M.S. Plummer, J. Cornicelli, H. Roark, D.J. Skalitzky, C.J. Stankovic, S. Bove, J. Pandit, A. Goodman, J. Hicks, A. Shahripour, D. Beidler, X.K. Lu, B. Sanchez, C. Whitehead, R. Sarver, T. Braden, R. Gowan, X.Q. Shen, K. Welch, A. Ogden, N. Sadagopan, H. Baum, H. Miller, C. Banotai, C. Spessard, and S. Lightle, Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: Optimization studies and demonstration of in vivo efficacy, Bioorg. Med. Chem. Lett. 23 (2013), pp. 3443–3447.
   PubMed Web of Science ®Google Scholar
• R.D. Cramer, D.E. Patterson, and J.D. Bunce, Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins, J. Am. Chem. Soc. 110 (1988), pp. 5959–5967.
   PubMed Web of Science ®Google Scholar
• G. Klebe, U. Abraham, and T. Mietzner, Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity, J. Med. Chem. 37 (1994), pp. 4130–4146.
   PubMed Web of Science ®Google Scholar
• R.D. Cramer, Topomer CoMFA: A design methodology for rapid lead optimization, J. Med. Chem. 46 (2003), pp. 374–388.
   PubMed Web of Science ®Google Scholar
• L.B. Salum and A.D. Andricopulo, Fragment-based QSAR: Perspectives in drug Design, Mol. Diversity 13 (2009), pp. 277–285.
   PubMed Web of Science ®Google Scholar
• M. Rarey, B. Kramer, T. Lengauer, and G.A. Klebe, A fast flexible docking method using an incremental construction algorithm, J. Mol. Biol. 261 (1996), pp. 470–489.
   PubMed Web of Science ®Google Scholar
• SYBYL X Molecular Modeling Software, Tripos Associates, V. 2.0, St Louis, USA, 2012; software available at http://www.tripos.com (under evaluation licence).
   Google Scholar
• M. Clark, R.D. Cramer, and N.J. Van Opdenbosh, Validation of the general purpose tripos 5.2 force field, Comput. Chem. 10 (1989), pp. 982–1012.
   Google Scholar
• A. Golbraikh and A. Tropsha, Beware of q2!, J. Mol. Graph. Model. 20 (2002), pp. 269–276.
   PubMed Web of Science ®Google Scholar
• S.S. Nilewar and M.K. Kathiravan, 3D CoMFA, CoMSIA, topomer CoMFA and HQSAR studies on aromatic acid esters for carbonic anhydrase inhibitory activity, J. Chemom. 28 (2014), pp. 60–70.
   Web of Science ®Google Scholar
• A.V. Raichurkar, U.A. Shah, and V.M. Kulkarni, 3D-QSAR of novel phosphodiesterase-4 inhibitors by genetic function approximation, Med. Chem. 7 (2011), pp. 543–552.
   PubMed Web of Science ®Google Scholar
• M.T. Makhija and V.M. Kulkarni, 3D-QSAR and molecular modeling of HIV-1 integrase inhibitors, J. Comput. Aid. Mol. Des. 16 (2002), pp. 181–200.
   PubMed Web of Science ®Google Scholar
• A.V. Raichurkar and V.M. Kulkarni, Understanding the antitumor activity of novel hydroxysemicarbazide derivatives as ribonucleotide reductase inhibitors using CoMFA and CoMSIA, J. Med. Chem. 46 (2003), pp. 4419–4427.
   PubMed Web of Science ®Google Scholar
• S.G. Bhansali and V.M. Kulkarni, 3D-QSAR of p38 mitogen activated protein kinase inhibitors: Pyridopyridazin-6-ones (part 1), Res. Rep. Med. Chem. 3 (2013), pp. 29–41.
   Google Scholar
• R.J. Jilek and R.D. Cramer, Topomers: A validated protocol for their self consistent generation, J. Chem. Inf. Comput. Sci. 44 (2004), pp. 1221–1227.
   PubMedGoogle Scholar
• R.D. Cramer, Leadhopping- and beyond, Expert Opin. Drug Discovery 1 (2006), pp. 1–12.
   PubMed Web of Science ®Google Scholar
• M.A. Avery, M. Alvim-Gaston, C.R. Rodrigues, E.J. Barreiro, F.E. Cohen, Y.A. Sabnis, and J.R. Woolfrey, Structure-activity relationships of the antimalarial agent artemisinin. 6. The development of predictive in vitro potency models using CoMFA and HQSAR methodologies, J. Med. Chem. 45 (2002), pp. 292–303.
   PubMed Web of Science ®Google Scholar
• Glide, version 5.8, Schrödinger LLC, New York, NY, 2012; software available at http://www.schrodinger.com.
   Google Scholar
• R.A. Friesner, J.L. Banks, R.B. Murphy, T.A. Halgren, J.J. Klicic, D.T. Mainz, M.P. Repasky, E.H. Knoll, M. Shelley, J.K. Perry, D.E. Shaw, P. Francis, and P.S. Shenkin, Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, J. Med. Chem. 47 (2004), pp. 1739–1749.
   PubMed Web of Science ®Google Scholar
• T.A. Halgren, R.B. Murphy, R.A. Friesner, H.S. Beard, L.L. Frye, W.T. Pollard, and J.L. Banks, Glide: A new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, J. Med. Chem. 47 (2004), pp. 1750–1759.
   PubMed Web of Science ®Google Scholar
• Maestro, version 9.3, Schrödinger LLC, New York, 2012; software available at http://www.schrodinger.com.
   Google Scholar
• LigPrep, version 2.5, Schrödinger LLC, New York, 2012; software available at http://www.schrodinger.com.
   Google Scholar
• S.G. Bhansali and V.M. Kulkarni, Pharmacophore generation, atom-based 3D-QSAR, docking, and virtual screening studies of p38-α mitogen activated protein kinase inhibitors: Pyridopyridazin-6-ones (part 2), Res. Rep. Med. Chem. 4 (2014), pp. 1–21.
   Google Scholar
• G. Chang, W.C. Guida, and W.C. Still, An internal-coordinate Monte Carlo method for searching conformational space, J. Am. Chem. Soc. 111 (1989), pp. 4379–4386.
   Web of Science ®Google Scholar
• I. Kolossvary and W.C. Guida, Low mode search. An efficient, automated computational method for conformational analysis: Application to cyclic and acyclic alkanes and cyclic peptides, J. Am. Chem. Soc. 118 (1996), pp. 5011–5019.
   Web of Science ®Google Scholar